Clinical significance of miRNA - 106a in non-small cell lung cancer patients who received cisplatin combined with gemcitabine chemotherapy

OBJECTIVE: Research has demonstrated that microRNA (miR)-106a is related to cisplatin resistance. We investigated the expression of miR-106a in the serum of patients with non-small cell lung cancer (NSCLC) and their sensitivity to chemotherapy by cisplatin combined with gemcitabine. METHODS: Eighty-...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Ye, Sun, Changyu, Zhang, Limeng, Pan, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Anti-Cancer Association 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994549/
https://www.ncbi.nlm.nih.gov/pubmed/29951339
http://dx.doi.org/10.20892/j.issn.2095-3941.2017.0182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994549/
https://www.ncbi.nlm.nih.gov/pubmed/29951339
http://dx.doi.org/10.20892/j.issn.2095-3941.2017.0182

Ejemplares similares